Figure 4.
Reduction from baseline in the psychological impact of submental fat (SMF) at 12 weeks after last treatment using the validated Patient-Reported SMF Impact Scale (PR-SMFIS). Lower scores indicate improvement or reduced negative impact. P < 0.001 for all comparisons between ATX-101 and placebo treatment.